Author:
,O’Leary Sean T.,Campbell James D.,Ardura Monica I.,Bryant Kristina A.,Caserta Mary T.,Espinosa Claudia,Frenck Robert W.,Healy C. Mary,John Chandy C.,Kourtis Athena P.,Milstone Aaron,Myers Angela,Pannaraj Pia,Ratner Adam J.,Bryant Kristina A.,Hofstetter Annika M.,Chaparro Juan D.,Michel Jeremy J.,Kimberlin David W.,Banerjee Ritu,Barnett Elizabeth D.,Lynfield Ruth,Sawyer Mark H.,Barton-Forbes Michelle,Cardemil Cristina V.,Farizo Karen M.,Kafer Lisa M.,Moore Denee,Okeke Chinedu,Prestel Chris,Patel Manisha,Starke Jeffrey R.,Thompson Jennifer,Torres Juan Pablo,Wharton Melinda,Woods Charles R.,Gibbs Gillian
Abstract
This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2024 to 2025 season. The rationale for the American Academy of Pediatrics recommendation for annual influenza vaccination of all children without medical contraindications starting at 6 months of age is provided. Influenza vaccination is an important strategy for protecting children and the broader community against influenza. This technical report summarizes recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, and vaccination coverage and provides detailed guidance on vaccine storage, administration, and implementation. The report also provides a brief background on inactivated (nonlive) and live attenuated influenza vaccines, available vaccines for the 2024–2025 influenza season, vaccination during pregnancy and breastfeeding, diagnostic testing for influenza, and antiviral medications for treatment and chemoprophylaxis. Strategies to promote vaccine uptake are emphasized.
Publisher
American Academy of Pediatrics (AAP)
Reference223 articles.
1. Committee on Infectious Diseases. Policy statement. Recommendations for prevention and control of influenza in children, 2024–2025;American Academy of Pediatrics;Pediatrics,2024
2. Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with influenza—United States, 2021-22 influenza season;Adams;MMWR Morb Mortal Wkly Rep,2022
3. Centers for Disease Control and Prevention. More than 100 flu-related deaths in children reported so far this season. Available at: https://www.cdc.gov/flu/spotlights/2023-2024/pediatric-flu-deaths.htm. Accessed March 10, 2024
4. Interim estimates of 2023–24 seasonal influenza vaccine effectiveness—United States;Frutos;MMWR Morb Mortal Wkly Rep,2024
5. Centers for Disease Control and Prevention Health Alert Network. Highly pathogenic avian influenza A(H5N1) virus: identification of human infection and recommendations for investigations and response. Available at: https://emergency.cdc.gov/han/2024/han00506.asp. Accessed April 29, 2024